N/A
Manufactured by Baxter Healthcare Corporation
20,322 FDA adverse event reports analyzed
Last updated: 2026-04-14
CEFAZOLIN SODIUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Baxter Healthcare Corporation. The most commonly reported adverse reactions for CEFAZOLIN SODIUM include HYPOTENSION, DRUG INEFFECTIVE, ANAPHYLACTIC REACTION, ANAPHYLACTIC SHOCK, RASH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CEFAZOLIN SODIUM.
Out of 11,565 classified reports for CEFAZOLIN SODIUM:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 20,322 FDA FAERS reports that mention CEFAZOLIN SODIUM. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include HYPOTENSION, DRUG INEFFECTIVE, ANAPHYLACTIC REACTION, ANAPHYLACTIC SHOCK, RASH, PYREXIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Baxter Healthcare Corporation in connection with CEFAZOLIN SODIUM. Always verify the specific product and NDC with your pharmacist.